The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ASTERIAS BIOTHERAPEUTICS INC | COM SER A | 04624N107 | 15,687 | 3,699,848 | SH | DFND | 1 | 3,699,848 | 0 | 0 | |
| ASTERIAS BIOTHERAPEUTICS INC | *W EXP 02/15/201 | 04624N115 | 171 | 328,205 | SH | DFND | 1 | 328,205 | 0 | 0 | |
| BIOTIME INC | COM | 09066L105 | 97,098 | 24,897,032 | SH | DFND | 1 | 24,897,032 | 0 | 0 | |
| CYNOSURE INC | CL A | 232577205 | 46,711 | 916,975 | SH | DFND | 1 | 916,975 | 0 | 0 | |
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | 52,168 | 420,000 | SH | DFND | 1 | 420,000 | 0 | 0 | |
| ONCOCYTE CORPORATION | COM | 68235C107 | 13,264 | 2,631,680 | SH | DFND | 1 | 2,631,680 | 0 | 0 | |
| MONSTER BEVERAGE CORP NEW | COM | 61174X109 | 234,769 | 1,599,136 | SH | DFND | 1 | 1,599,136 | 0 | 0 | |
| MALLINCKRODT PUB LTD CO | SHS | G5785G107 | 22,498 | 322,411 | SH | DFND | 1 | 322,411 | 0 | 0 | |
| STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 102,039 | 10,855,179 | SH | DFND | 1 | 10,855,179 | 0 | 0 | |